earnings
confidence high
sentiment positive
materiality 0.80
Dexcom Q3 revenue $769.6M (+18% YoY); non-GAAP EPS $0.28; guides FY22 ~$2.88-2.91B
DEXCOM INC
2022-Q3 EPS reported
$0.60
revenue$2,094,600,000
- Revenue $769.6M, up 18% reported, 20% organic; US +17%, international +22% reported (+28% organic).
- GAAP net income $101.2M ($0.24 EPS); non-GAAP net income $111.9M ($0.28 EPS).
- Non-GAAP operating margin 20.9% (up 190 bps YoY); GAAP operating income $147.5M.
- Initiated international rollout of Dexcom G7 in UK, Ireland, Germany, Austria, Hong Kong.
- FY22 revenue guidance updated to ~$2.88-2.91B (18-19% growth); non-GAAP operating margin ~16%.